Skip to main content

RHUMBLINE ADVISERS

Position in TNGX — Tango Therapeutics, Inc.

CIK 1115418 BOSTON, MA

Position in TNGX

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$2,648,534
+$1,504,646 QoQ
Shares Held
126,603
-1.9% QoQ
Ownership
0.088%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2022
16 quarters on record
Voting authority Sole 18.043016358222157.ToString("F0")% Shared 0.ToString("F0")% None 81.95698364177784.ToString("F0")%

Common Shares in TNGX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

RHUMBLINE ADVISERS holds $1,237,848,251 across 287 Biotechnology names. TNGX ranks #69 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TNGX

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,648,534 126,603
2025-12-31 $1,143,888 129,107
2025-09-30 $905,847 107,839
2025-06-30 $574,837 112,273
2025-03-31 $91,524 66,806
2024-12-31 $203,136 65,740
2024-09-30 $491,606 63,845
2024-06-30 $577,777 67,340
2024-03-31 $567,209 71,437
2023-12-31 $696,861 70,390
2023-09-30 $785,565 69,766
2023-06-30 $234,475 70,625
2023-03-31 $283,297 71,721
2022-12-31 $512,502 70,690
2022-09-30 $252,502 69,752
2022-06-30 $298,681 65,934